EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY.
Saved in:
| Title: | EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY. |
|---|---|
| Authors: | Gandhi, M.K., Hoang, T., Tobin, J.W., Law, S.C., Talaulikar, D., Jain, S., Vari, F., Murigneux, V., Fink, L., Gunawardana, J., Gould, C., Oey, H., Delecluse, S., Trappe, R.U., Merida de Long, L., Sabdia, M.B., Bhagat, G., Hapgood, G., Blyth, E., Clancy, L., et al |
| Source: | Hematological oncology Jun2019 Supplement S2; Vol. 37. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: EPTOC137029539 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gandhi%2C+M%2EK%2E%22">Gandhi, M.K.</searchLink><br /><searchLink fieldCode="AU" term="%22Hoang%2C+T%2E%22">Hoang, T.</searchLink><br /><searchLink fieldCode="AU" term="%22Tobin%2C+J%2EW%2E%22">Tobin, J.W.</searchLink><br /><searchLink fieldCode="AU" term="%22Law%2C+S%2EC%2E%22">Law, S.C.</searchLink><br /><searchLink fieldCode="AU" term="%22Talaulikar%2C+D%2E%22">Talaulikar, D.</searchLink><br /><searchLink fieldCode="AU" term="%22Jain%2C+S%2E%22">Jain, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Vari%2C+F%2E%22">Vari, F.</searchLink><br /><searchLink fieldCode="AU" term="%22Murigneux%2C+V%2E%22">Murigneux, V.</searchLink><br /><searchLink fieldCode="AU" term="%22Fink%2C+L%2E%22">Fink, L.</searchLink><br /><searchLink fieldCode="AU" term="%22Gunawardana%2C+J%2E%22">Gunawardana, J.</searchLink><br /><searchLink fieldCode="AU" term="%22Gould%2C+C%2E%22">Gould, C.</searchLink><br /><searchLink fieldCode="AU" term="%22Oey%2C+H%2E%22">Oey, H.</searchLink><br /><searchLink fieldCode="AU" term="%22Delecluse%2C+S%2E%22">Delecluse, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Trappe%2C+R%2EU%2E%22">Trappe, R.U.</searchLink><br /><searchLink fieldCode="AU" term="%22Merida+de+Long%2C+L%2E%22">Merida de Long, L.</searchLink><br /><searchLink fieldCode="AU" term="%22Sabdia%2C+M%2EB%2E%22">Sabdia, M.B.</searchLink><br /><searchLink fieldCode="AU" term="%22Bhagat%2C+G%2E%22">Bhagat, G.</searchLink><br /><searchLink fieldCode="AU" term="%22Hapgood%2C+G%2E%22">Hapgood, G.</searchLink><br /><searchLink fieldCode="AU" term="%22Blyth%2C+E%2E%22">Blyth, E.</searchLink><br /><searchLink fieldCode="AU" term="%22Clancy%2C+L%2E%22">Clancy, L.</searchLink><br />et al – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> Jun2019 Supplement S2; Vol. 37. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>ISSN: </i>0278-0232 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC137029539 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/hon.91_2629 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 130 Titles: – TitleFull: EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gandhi, M.K. – PersonEntity: Name: NameFull: Hoang, T. – PersonEntity: Name: NameFull: Tobin, J.W. – PersonEntity: Name: NameFull: Law, S.C. – PersonEntity: Name: NameFull: Talaulikar, D. – PersonEntity: Name: NameFull: Jain, S. – PersonEntity: Name: NameFull: Vari, F. – PersonEntity: Name: NameFull: Murigneux, V. – PersonEntity: Name: NameFull: Fink, L. – PersonEntity: Name: NameFull: Gunawardana, J. – PersonEntity: Name: NameFull: Gould, C. – PersonEntity: Name: NameFull: Oey, H. – PersonEntity: Name: NameFull: Delecluse, S. – PersonEntity: Name: NameFull: Trappe, R.U. – PersonEntity: Name: NameFull: Merida de Long, L. – PersonEntity: Name: NameFull: Sabdia, M.B. – PersonEntity: Name: NameFull: Bhagat, G. – PersonEntity: Name: NameFull: Hapgood, G. – PersonEntity: Name: NameFull: Blyth, E. – PersonEntity: Name: NameFull: Clancy, L. IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: Jun2019 Supplement S2 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 1099-1069 Numbering: – Type: volume Value: 37 Titles: – TitleFull: Hematological oncology Type: main |
| ResultId | 1 |